Contribution of intravenous immunoglobulins to the treatment of myasthenia (Ann. Med. Interne (Paris).— 2000. May. —151. Suppl. 1. — 1S30—4: Франц.)

P. Gajdos

doi:10.17816/nb79794

Neurology Bulletin ›› 2001, Vol. XXXIII ›› Issue (1-2) : 114 -115. DOI: 10.17816/nb79794

Articles

book-review

Contribution of intravenous immunoglobulins to the treatment of myasthenia (Ann. Med. Interne (Paris).— 2000. May. —151. Suppl. 1. — 1S30—4: Франц.)

P. Gajdos

Author information +

History +

PDF

Abstract

Myasthenia gravis is an autoimmune disease characterized by the production of autoantibodies against acetylcholine receptors at the end plate of the neuromuscular synapse.

Keywords

Bekhterev neurology archive

Cite this article

Download citation ▾

P. Gajdos. Contribution of intravenous immunoglobulins to the treatment of myasthenia (Ann. Med. Interne (Paris).— 2000. May. —151. Suppl. 1. — 1S30—4: Франц.). Neurology Bulletin, 2001, XXXIII(1-2): 114-115 DOI:10.17816/nb79794